Postma MJ - Search Results

1

BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles.

Dunlop WC, Mullins CD, Pirk O, Goeree R, Postma MJ, Enstone A, Heron L. Dunlop WC, et al. Among authors: postma mj. Pharmacoeconomics. 2016 Oct;34(10):1051-65. doi: 10.1007/s40273-016-0427-7. Pharmacoeconomics. 2016. PMID: 27378386 Free PMC article. Review.

2

Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.

Vegter S, Boersma C, Rozenbaum M, Wilffert B, Navis G, Postma MJ. Vegter S, et al. Among authors: postma mj. Pharmacoeconomics. 2008;26(7):569-87. doi: 10.2165/00019053-200826070-00005. Pharmacoeconomics. 2008. PMID: 18563949 Review.

3

Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence.

Pechlivanoglou P, De Vries R, Daenen SM, Postma MJ. Pechlivanoglou P, et al. Among authors: postma mj. Pharmacoeconomics. 2011 Sep;29(9):737-51. doi: 10.2165/11588370-000000000-00000. Pharmacoeconomics. 2011. PMID: 21657801 Review.

4

Differential time preferences for money and quality of life.

Parouty MB, Le HH, Krooshof D, Postma MJ. Parouty MB, et al. Among authors: postma mj. Pharmacoeconomics. 2014 Apr;32(4):411-9. doi: 10.1007/s40273-013-0124-8. Pharmacoeconomics. 2014. PMID: 24464352

5

Which factors enhance positive drug reimbursement recommendation in Scotland? A retrospective analysis 2006-2013.

Charokopou M, Majer IM, Raad Jd, Broekhuizen S, Postma M, Heeg B. Charokopou M, et al. Value Health. 2015 Mar;18(2):284-91. doi: 10.1016/j.jval.2014.12.008. Epub 2015 Feb 4. Value Health. 2015. PMID: 25773564 Free article.

6

Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments.

Zakiyah N, Postma MJ, Baker PN, van Asselt AD; IMPROvED Consortium. Zakiyah N, et al. Among authors: postma mj. Pharmacoeconomics. 2015 Oct;33(10):1069-82. doi: 10.1007/s40273-015-0291-x. Pharmacoeconomics. 2015. PMID: 26048352 Free PMC article. Review.

7

Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations.

van der Schans S, Goossens LMA, Boland MRS, Kocks JWH, Postma MJ, van Boven JFM, Rutten-van Mölken MPMH. van der Schans S, et al. Among authors: postma mj. Pharmacoeconomics. 2017 Jan;35(1):43-63. doi: 10.1007/s40273-016-0448-2. Pharmacoeconomics. 2017. PMID: 27592021 Free PMC article. Review.

8

Access to anti-cancer drugs in India: is there a need to revise reimbursement policies?

Haitsma G, Patel H, Gurumurthy P, Postma MJ. Haitsma G, et al. Among authors: postma mj. Expert Rev Pharmacoecon Outcomes Res. 2018 Jun;18(3):289-296. doi: 10.1080/14737167.2018.1444479. Epub 2018 Feb 26. Expert Rev Pharmacoecon Outcomes Res. 2018. PMID: 29466887

9

Cost Effectiveness of Human Papillomavirus Vaccination for Men Who have Sex with Men; Reviewing the Available Evidence.

Setiawan D, Wondimu A, Ong K, van Hoek AJ, Postma MJ. Setiawan D, et al. Among authors: postma mj. Pharmacoeconomics. 2018 Aug;36(8):929-939. doi: 10.1007/s40273-018-0649-y. Pharmacoeconomics. 2018. PMID: 29679316

10

A novel perspective on pharmaceutical R&D costs: opportunities for reductions.

van der Schans S, De Loos F, Boersma C, Postma MJ, Büller H. van der Schans S, et al. Among authors: postma mj. Expert Rev Pharmacoecon Outcomes Res. 2022 Mar;22(2):167-175. doi: 10.1080/14737167.2022.1987219. Epub 2021 Oct 21. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 34595997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

644 results

Search Page